{{DISPLAYTITLE:5-HT<sub>3</sub> receptor}}

The '''5-HT<sub>3</sub> receptor''' is a member of the superfamily of [[ligand-gated ion channel]]s, a superfamily that also includes the neuronal [[nicotinic acetylcholine receptor]]s (nAChRs), and the inhibitory neurotransmitter receptors for [[Gamma-aminobutyric acid|GABA]] (both [[GABA A receptor|GABA<SUB>A</SUB>]] and [[GABAA-rho receptor|GABA<sub>A</sub>-ρ]] receptors) and [[glycine receptor|glycine]].<ref name="Maricq_1991">{{Cite journal|author=Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D|title=Primary structure and functional expression of the 5HT<sub>3</sub> receptor, a serotonin-gated ion channel|journal= Science |volume= 254 |issue= 5030 |pages= 432–7 |year= 1991| doi = 10.1126/science.1718042 |pmid= 1718042}}</ref><ref name="Yakel_2000">{{Cite book| last=Yakel | first=JL | year=2000 | editor-last=Endo | editor-first=M | editor2-last=Kurachi | editor2-first=Y | editor3-last=Mishina | editor3-first=M | title=The 5-HT<sub>3</sub> receptor channel: function, activation and regulation in Pharmacology of Ionic Channel Function: Activators and Inhibitors (Handbook of Experimental Pharmacology) | place=Berlin | publisher=[[Springer-Verlag]] | publication-date= | volume=147 | pages=541–560 | isbn=3-540-66127-1 | postscript=<!--None-->}}</ref>  The 5-HT<sub>3</sub> receptor is most closely related by homology to the nicotinic acetylcholine receptor.

The 5-HT<sub>3</sub> receptor consists of 5 subunits arranged around a central ion conducting pore, which is permeable to sodium, potassium, and calcium ions.  Binding of the [[neurotransmitter]] 5-hydroxytryptamine ([[serotonin]]) to the 5-HT<sub>3</sub> receptor opens the channel, which, in turn, leads to an excitatory response in neurons.  The 5-HT<sub>3</sub> receptor differs markedly in structure and mechanism from the other [[5-HT receptor]] subtypes, which are all [[G-protein-coupled receptor|G-protein-coupled]].

==Structure==
As with other ligand gated ion channels, the 5-HT<sub>3</sub> receptor is composed of five subunits pseudo symmetrically arranged about a central ion conducting pore.   These subunits are proteins encoded by the {{Gene|HTR3A}}, {{Gene|HTR3B}}, {{Gene|HTR3C}}, {{Gene|HTR3D}}, and/or {{Gene|HTR3E}} genes.

A functional channel may be composed of five identical [[HTR3A|5-HT<sub>3A</sub>]] subunits (homopentameric) or a mixture of 5-HT<sub>3A</sub> and one of the other four 5-HT<sub>3B</sub>,<ref name="van Davies_1999">{{Cite journal|author=Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF|title=The 5-HT<sub>3B</sub> subunit is a major determinant of serotonin-receptor function|journal= Nature |volume= 397 |issue= 6717 |pages= 359–63 |year= 1999| doi = 10.1038/16941 |pmid= 9950429}}</ref><ref name="van Dubin_1999">{{Cite journal|author=Dubin AE, Huvar R, D'Andrea MR, Pyati J, Zhu JY, Joy KC, Wilson SJ, Galindo JE, Glass CA, Luo L, Jackson MR, Lovenberg TW, Erlander MG|title=The pharmacological and functional characteristics of the serotonin 5-HT<sub>3A</sub> receptor are specifically modified by a 5-HT<sub>3B</sub> receptor subunit|journal= J Biol Chem |volume= 274 |issue= 43 |pages= 30799–810 |year= 1999| doi = 10.1074/jbc.274.43.30799|pmid= 10521471}}</ref><ref name="van Monk_2001">{{Cite journal|author=Monk SA, Desai K, Brady CA, Williams JM, Lin L, Princivalle A, Hope AG, Barnes NM|title=Generation of a selective 5-HT<sub>3B</sub> subunit-recognising polyclonal antibody; identification of immunoreactive cells in rat hippocampus|journal= Neuropharmacology |volume= 41 |issue= 8 |pages= 1013–6 |year= 2001| doi = 10.1016/S0028-3908(01)00153-8 |pmid= 11747906}}</ref><ref name="Boyd">{{Cite journal|author=Boyd GW, Low P, Dunlop JI, Ward M, Vardy AW, Lambert JJ, Peters J, Conolly CN|title= Assembly and cell surface expression of homomeric and heteromeric 5-HT3 receptors: The role of oligomerisation and chaperone proteins|journal= Mol Cell Neurosci |volume= 21 |issue= 1 |pages= 38–50 |year= 2002 |pmid= 12359150 | doi = 10.1006/mcne.2002.1160 }}</ref> 5-HT<sub>3C</sub>, 5-HT<sub>3D</sub>, or 5-HT<sub>3E</sub> subunits (heteropentameric).<ref name="Niesler_2007">{{Cite journal|author=Niesler B, Walstab J, Combrink S, Moeller D, Kapeller J, Rietdorf J, Boenisch H, Goethert M, Rappold G, Bruess M|title=Characterization of the Novel Human Serotonin Receptor Subunits 5-HT<sub>3C</sub>, 5- HT<sub>3D</sub> and 5-HT<sub>3E</sub>|journal= Mol Pharmacol |volume= 71 |issue= Mar 28 |pages= 8–17 |year= 2007| doi = 10.1124/mol.106.032144 |pmid= 17392525}}</ref> It appears that only the 5-HT<sub>3A</sub> subunits form functional homopentameric channels.  All other subunit subtypes must heteropentamerize with 5-HT<sub>3A</sub> subunits to form functional channels.

==Tissue distribution==
The 5-HT<sub>3</sub> receptor is expressed throughout the [[central nervous system|central]] and [[peripheral nervous system]]s and mediates a variety of physiological functions.<ref name="Yakel_2000"/>  On a cellular level, it has been shown that postsynaptic 5-HT<sub>3</sub> receptors mediate fast excitatory synaptic transmission in rat neocortical interneurons, [[amygdala]], and hippocampus, and in ferret [[visual cortex]].<ref name="Ferezou_1991">{{Cite journal|author=Férézou I, Cauli B, Hill EL, Rossier J, Hamel E, Lambolez B|title=5-HT<sub>3</sub> receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons|journal= J Neurosci |volume= 22 |issue= 17 |pages= 7389–97 |year= 2002| doi = |pmid= 12196560}}</ref><ref name="Kawa_1994">{{Cite journal|author=Kazuyoshi Kawa|title=Distribution and Functional Properties of 5HT<sub>3</sub> Receptors in the Rat Hippocampus Dentate Gyrus|journal= Journal of Neurophysiology |volume= 71 |issue= 5 |pages= 1935–47 |year= 1994| doi = 10.1113/jphysiol.2009.183137 |pmid= 19933751}}</ref><ref name="Sugita_1992">{{Cite journal|author=Sugita S, Shen KZ, North RA|title=5-hydroxytryptamine is a fast excitatory transmitter at 5-HT<sub>3</sub> receptors in rat amygdala|journal= Neuron |volume= 8 |issue= 1 |pages= 199–203 |year= 1992| doi = 10.1016/0896-6273(92)90121-S |pmid= 1346089}}</ref><ref name="Roerig_1997">{{Cite journal|author=Roerig B, Nelson DA, Katz LC|title=Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT<sub>3</sub> receptors in developing visual cortex|journal= J Neurosci |volume= 17 |issue= 21 |pages= 199–203 |year= 1992| doi = |pmid= 9334409}}</ref>  5-HT<sub>3</sub> receptors are also present on presynaptic nerve terminals, where they are thought to mediate or modulate neurotransmitter release.<ref name="Ronde_1998">{{Cite journal|author=Rondé P, Nichols RA|title=High calcium permeability of serotonin 5-HT<sub>3</sub> receptors on presynaptic nerve terminals from rat striatum|journal= J Neurochem |volume= 70 |issue= 3 |pages= 1094–103 |year= 1998| doi = 10.1046/j.1471-4159.1998.70031094.x |pmid= 9489730}}</ref><ref name="Ronde_1997">{{Cite journal|author=Rondé P, Nichols RA|title=5-HT<sub>3</sub> receptors induce rises in cytosolic and nuclear calcium in NG108-15 cells via calcium-induced calcium release|journal= Cell Calcium |volume= 22 |issue= 5 |pages= 357–65 |year= 1997| doi = 10.1016/S0143-4160(97)90020-8|pmid= 9448942}}</ref><ref name="van Hooft_2000">{{Cite journal|author=van Hooft JA, Vijverberg HP|title=5-HT<sub>3</sub> receptors and neurotransmitter release in the CNS: a nerve ending story?|journal= Trends Neurosci |volume= 23 |issue= 12 |pages= 605–10 |year= 2000| doi = 10.1016/S0166-2236(00)01662-3 |pmid= 11137150}}</ref>

==Effects==
When the receptor is activated to open the ion channel by [[agonists]], the following effects are observed:
* [[central nervous system|CNS]]: nausea and vomiting center in [[brain stem]], anxiety,<ref name="Rang187"/> seizure propensity <ref>{{cite journal |author= Gholipour T, Ghasemi M, Riazi K, Ghaffarpour M, Dehpour AR.|title= Seizure susceptibility alteration through 5-HT(3) receptor: modulation by nitric oxide|journal= Seizure |volume=19|issue=1 |pages=17–22 |year=2010 |month=January |pmid=19942458 |doi=10.1016/j.seizure.2009.10.006}}</ref>
* [[peripheral nervous system|PNS]]: neuronal excitation (in autonomic, nociceptive neurons), [[emesis]]<ref name="Rang187"/>

==Agonists==
Agonists for the receptor include:
* [[2-methyl-5-HT]]
* [[Ethanol]]
* [[Alpha-Methyltryptamine]]
* [[varenicline]]<ref name="pmid20965579">{{cite journal |author=Mineur YS, Picciotto MR |title=Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis |journal=Trends Pharmacol. Sci. |volume=31 |issue=12 |pages=580–6 |year=2010 |month=December |pmid=20965579 |pmc=2991594 |doi=10.1016/j.tips.2010.09.004 }}</ref>
* [[Chlorophenylbiguanide]]<ref name="Rang187"/>
* [[Quipazine]]
* [[RS-56812]]: potent and selective 5-HT<sub>3</sub> partial agonist, 1000x selectivity over other serotonin receptors
* [[SR-57227]]
* [[YM-31636]]<ref>{{cite journal | last1 = Imanishi | first1 = N | last2 = Iwaoka | first2 = K | last3 = Koshio | first3 = H | last4 = Nagashima | first4 = SY | last5 = Kazuta | first5 = K | last6 = Ohta | first6 = M | last7 = Sakamoto | first7 = S | last8 = Ito | first8 = H | last9 = Akuzawa | first9 = S | title = New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation | journal = Bioorganic & Medicinal Chemistry | volume = 11 | issue = 7 | pages = 1493–502 | year = 2003 | pmid = 12628674 | doi=10.1016/S0968-0896(02)00557-6}}</ref>

==Antagonists==
{{See also|5-HT3 receptor antagonist:drug discovery and development|l1=5-HT<sub>3</sub> receptor antagonist: Drug discovery and development}}

Antagonists for the receptor (sorted by their respective therapeutic application) include:
* [[Antiemetic]]s
** [[AS-8112]]
** [[Granisetron]]<ref name="Rang187"/>
** [[Ondansetron]]
** [[Tropisetron]]<ref name="Rang187">{{Cite book|author=Rang, H. P. |title=Pharmacology |publisher=Churchill Livingstone |location=Edinburgh |year=2003 |pages= |isbn=0-443-07145-4 |oclc= |doi=}} Page 187</ref>
* [[Gastroprokinetic]]s
** [[Alosetron]]
** [[Batanopride]]
** [[Metoclopramide]] (high doses)
** [[Renzapride]]
** [[Zacopride]]
* [[Antidepressant]]s
** [[Mianserin]]
** [[Mirtazapine]]
* [[Antipsychotic]]s
** [[Clozapine]]
** [[Olanzapine]]
** [[Quetiapine]]
* Others
** [[Memantine]] ([[Alzheimer's disease]] medication)

==Discovery==
Identification of the 5-HT<sub>3</sub> receptor did not take place until 1986 because of a lack of selective pharmacological tool.<ref name="Yakel_2000"/> However, with the discovery that the 5-HT<sub>3</sub> receptor plays a prominent role in [[chemotherapy]]- and [[radiotherapy]]-induced [[vomiting]], and the concomitant development of selective [[5-HT3 antagonist|5-HT<sub>3</sub> receptor antagonist]]s to suppress these side effects aroused intense interest from the pharmaceutical industry<ref name="Thompson_2006">{{Cite journal|author=Thompson AJ, Lummis SC|title=5-HT3 Receptors|journal= Curr Pharm Des |volume= 12 |issue= 28 |pages= 3615–30 |year= 2006| url = http://www.ingentaconnect.com/content/ben/cpd/2006/00000012/00000028/art00005 | doi =  10.2174/138161206778522029|pmid= 17073663 |pmc=2664614}}</ref><ref name="Thompson_2007">{{Cite journal|author=Thompson AJ, Lummis SC|title=The 5-HT3 receptor as a therapeutic target|journal= Expert Opin Ther Targets |volume= 11 |issue= 4 |pages= 527–40 |year= 2007| doi = 10.1517/14728222.11.4.527 |pmid= 17373882 |pmc=1994432}}</ref> and therefore the identification of 5-HT<sub>3</sub> receptors in cell lines and native tissues quickly followed.<ref name="Yakel_2000"/>

==References==
{{Reflist|2}}

==External links==
* {{MeshName|5-HT3+Receptor}}

{{Ligand-gated ion channels}}
{{Serotonergics}}

{{DEFAULTSORT:5-Ht3 Receptor}}
[[Category:Ion channels]]
[[Category:Ionotropic receptors]]
[[Category:Serotonin]]